Relmada Therapeutics
RLMD
#9903
Rank
โ‚น0.97 B
Marketcap
โ‚น32.31
Share price
4.60%
Change (1 day)
-88.15%
Change (1 year)

Relmada Therapeutics (RLMD) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น0.68 Billion

According to Relmada Therapeutics's latest financial reports the company's total liabilities are โ‚น0.68 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Relmada Therapeutics - Total liabilities on balance sheet (from 2012 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚น1.03 B-7.96%
2021-12-31โ‚น1.12 B21.62%
2020-12-31โ‚น0.92 B
2019-06-30โ‚น0.17 B-69.33%
2018-06-30โ‚น0.58 B557.02%
2017-06-30โ‚น89.18 M-58.68%
2016-06-30โ‚น0.21 B-78.26%
2015-06-30โ‚น0.99 B-38.45%
2014-06-30โ‚น1.61 B
2013-08-31โ‚น2.24 M476.87%
2012-08-31โ‚น0.38 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น32.69 B 4,642.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚น123.43 B 17,802.37%๐Ÿ‡บ๐Ÿ‡ธ USA